BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17612284)

  • 1. Recombinant human granulocyte colony-stimulating factor administration in a case of neutropenia due to increased neutrophil sequestration.
    Carulli G; Lazzeri E; Lagomarsini G; Zucca A; Cannizzo E; Riccioni R; Petrini M
    Clin Ter; 2007; 158(3):235-7. PubMed ID: 17612284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human granulocyte colony-stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection.
    Rewerts JM; McCaw DL; Cohn LA; Wagner-Mann C; Harrington D
    J Am Vet Med Assoc; 1998 Oct; 213(7):991-2. PubMed ID: 9776994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of successful hypospadias repair without infection using recombinant human granulocyte-colony stimulating factor (rhG-CSF) for idiopathic neutropenia].
    Kojima Y; Hayashi Y; Umemoto Y; Sakakura T; Sasaki S; Kohri K; Kato F
    Hinyokika Kiyo; 1998 Jun; 44(6):419-21. PubMed ID: 9719943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
    Shochat E; Rom-Kedar V
    Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with "idiopathic neonatal neutropenia": a randomized, placebo-controlled trial.
    Juul SE; Christensen RD
    J Perinatol; 2003 Sep; 23(6):493-7. PubMed ID: 13679938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
    Kuritzkes DR
    Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of granulocyte colony-stimulating factor: an update and summary.
    Hübel K; Engert A
    Ann Hematol; 2003 Apr; 82(4):207-13. PubMed ID: 12707722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of recombinant human granulocyte colony stimulating factor in children with acute myeloid leukemia.
    Shang X; Yin H; Lu A; Zhang L
    Chin Med J (Engl); 1999 Jul; 112(7):620-2. PubMed ID: 11601256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor.
    Duffy A; Dow S; Ogilvie G; Rao S; Hackett T
    J Vet Pharmacol Ther; 2010 Aug; 33(4):352-6. PubMed ID: 20646196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulins for neonatal alloimmune neutropenia refractory to recombinant human granulocyte colony-stimulating factor.
    Desenfants A; Jeziorski E; Plan O; Rodière M; Rimbert M; Muller JY; Taïb J; Cambonie G
    Am J Perinatol; 2011 Jun; 28(6):461-6. PubMed ID: 21136350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections.
    Euler HH; Harten P; Zeuner RA; Schwab UM
    J Rheumatol; 1997 Nov; 24(11):2153-7. PubMed ID: 9375876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human granulocyte colony-stimulating factor administration on neutrophil phenotype and functions.
    Carulli G
    Haematologica; 1997; 82(5):606-16. PubMed ID: 9407734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
    Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
    Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor induced reduction in pulpal necrosis.
    Yamasaki M; Nakamura K; Amano K; Matsui H; Nakamura H
    Int Endod J; 2008 Jul; 41(7):593-601. PubMed ID: 18479372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and purification of canine granulocyte colony-stimulating factor (cG-CSF).
    Yamamoto A; Iwata A; Saito T; Watanabe F; Ueda S
    Vet Immunol Immunopathol; 2009 Aug; 130(3-4):221-5. PubMed ID: 19339059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.